Javelin Medical Overview
Javelin Medical is developing a device to prevent stroke in individuals with abnormal heart rhythm (atrial fibrillation). The company's device, Vine, is a permanent filter implanted in the carotid arteries designed to prevent strokes from occurring by intercepting blood clots. Vine is implanted through a thin needle in a short, simple procedure. It is currently available for individuals with atrial fibrillation through participation in the CAPTURE II study in several European countries.
Latest News
growth-positive
Novel Carotid Filter Aims for Stroke Prevention in Afib
A pilot trial showed that stroke prophylaxis with a novel permanent filter implanted in the carotid arteries is feasible for high-risk atrial fibrillation (Afib) patients. The Vine coil filter, developed by Javelin Medical, was successfully placed in 92% of patients without major adverse events. The device caught emboli in four patients, which were dissolved with subcutaneous heparin. The trial was not powered to assess clinical outcomes, but a single patient had two minor strokes unrelated to the device. The CAPTURE trial included 25 patients who were unsuitable for oral anticoagulants. The filter is made of super-elastic nitinol wire and has a circular cross-section. The trial was supported by Javelin Medical and a grant from the Czech Ministry of Health.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.javelinmed.com |
Locations
Ha-Kidma Street 27, Yokne'am Illit, Israel
Photos & Videos
No files yet
